Leukocyte Derived Microvesicles as Disease Progression Biomarkers in Slow Progressing Amyotrophic Lateral Sclerosis Patients

The lack of biomarkers in Amyotrophic Lateral Sclerosis (ALS) makes it difficult to determine the stage of the disease in patients and, therefore, it delays therapeutic trials. Microvesicles (MVs) are possible biomarkers implicated in physiological and pathological functions, however, their role in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sproviero, Daisy, La Salvia, Sabrina, Colombo, Federico, Zucca, Susanna, Pansarasa, Orietta, Diamanti, Luca, Costa, Alfredo, Lova, Luca, Giannini, Marta, Gagliardi, Stella, Lauranzano, Eliana, Matteoli, Michela, Ceroni, Mauro, Malaspina, Andrea, Cereda, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476347/
https://www.ncbi.nlm.nih.gov/pubmed/31037054
http://dx.doi.org/10.3389/fnins.2019.00344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476347/
https://www.ncbi.nlm.nih.gov/pubmed/31037054
http://dx.doi.org/10.3389/fnins.2019.00344

Ejemplares similares